PML enhances the regulation of p53 by CK1 in response to DNA damage

In response to stress, p53 is accumulated and activated to induce appropriate growth inhibitory responses. This requires the release of p53 from the constraints of its negative regulators Mdm2 and Mdm4. A key event in this dissociation is the phosphorylation of p53 at threonine residue (Thr18) within the Mdm2/4-binding domain. Casein kinase 1 (CK1) plays a major role in this phosphorylation. The promyelocytic leukemia protein (PML) regulates certain modifications of p53 in response to DNA damage. Here, we investigated the role of PML in the regulation of Thr18 phosphorylation. We found that PML enhances Thr18 phosphorylation of endogenous p53 in response to stress. On DNA damage, CK1 accumulates in the cell, with a proportion concentrated in the nucleus together with p53 and PML. Furthermore, CK1 interacts with endogenous p53 and PML, and this interaction is enhanced by genotoxic stress. Inhibition of CK1 impairs the protection of p53 by PML from Mdm2-mediated degradation. Our findings support a role for PML in the regulation of p53 by CK1. We propose that following DNA damage, PML facilitates Thr18 phosphorylation by recruiting p53 and CK1 into PML nuclear bodies, thereby protecting p53 from inhibition by Mdm2, leading to p53 activation.

[1]  A. Ciechanover,et al.  c-Abl Regulates p53 Levels under Normal and Stress Conditions by Preventing Its Nuclear Export and Ubiquitination , 2001, Molecular and Cellular Biology.

[2]  S. Ferrari,et al.  Wt-p53 action in human leukaemia cell lines corresponding to different stages of differentiation. , 1998, British Journal of Cancer.

[3]  M. Stöter,et al.  Casein kinase 1 delta (CK1delta) interacts with the SNARE associated protein snapin. , 2006, FEBS letters.

[4]  M. Stöter,et al.  IC261, a specific inhibitor of the protein kinases casein kinase 1-delta and -epsilon, triggers the mitotic checkpoint and induces p53-dependent postmitotic effects , 2000, Oncogene.

[5]  Pier Paolo Pandolfi,et al.  The Promyelocytic Leukemia Protein Protects p53 from Mdm2-mediated Inhibition and Degradation* , 2003, Journal of Biological Chemistry.

[6]  Michael A. Dyer,et al.  MDMX: from bench to bedside , 2007, Journal of Cell Science.

[7]  U. Knippschild,et al.  p53 is phosphorylated in vitro and in vivo by the delta and epsilon isoforms of casein kinase 1 and enhances the level of casein kinase 1 delta in response to topoisomerase-directed drugs , 1997, Oncogene.

[8]  A. Dejean,et al.  Trivalent antimonials induce degradation of the PML-RAR oncoprotein and reorganization of the promyelocytic leukemia nuclear bodies in acute promyelocytic leukemia NB4 cells. , 1998, Blood.

[9]  Andreas Gocht,et al.  The casein kinase 1 family: participation in multiple cellular processes in eukaryotes. , 2005, Cellular signalling.

[10]  D. Meek,et al.  The p53 response to DNA damage. , 2004, DNA repair.

[11]  T. Maritzen,et al.  Casein kinase I delta (CKIdelta) is involved in lymphocyte physiology. , 2003, European journal of cell biology.

[12]  H. de Thé,et al.  Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[13]  P. Pandolfi,et al.  Loss of the tumor suppressor PML in human cancers of multiple histologic origins. , 2004, Journal of the National Cancer Institute.

[14]  P. Pandolfi,et al.  PML is a direct p53 target that modulates p53 effector functions. , 2004, Molecular cell.

[15]  D. Meek,et al.  p53 Is Phosphorylated in Vitro and in Vivo by an Ultraviolet Radiation-induced Protein Kinase Characteristic of the c-Jun Kinase, JNK1 (*) , 1995, The Journal of Biological Chemistry.

[16]  S. Minucci,et al.  Human SIR2 deacetylates p53 and antagonizes PML/p53‐induced cellular senescence , 2002, The EMBO journal.

[17]  N. Gueven,et al.  The complexity of p53 stabilization and activation , 2006, Cell Death and Differentiation.

[18]  Martin Egli,et al.  Crystal Structure of a Conformation-selective Casein Kinase-1 Inhibitor* , 2000, The Journal of Biological Chemistry.

[19]  P. Pandolfi,et al.  p53 de-ubiquitination: at the edge between life and death , 2002, Nature Cell Biology.

[20]  B. Vojtesek,et al.  Novel phosphorylation sites of human tumour suppressor protein p53 at Ser20 and Thr18 that disrupt the binding of mdm2 (mouse double minute 2) protein are modified in human cancers. , 1999, The Biochemical journal.

[21]  R. Copeland,et al.  Thermodynamics of p53 binding to hdm2(1-126): effects of phosphorylation and p53 peptide length. , 2000, Archives of biochemistry and biophysics.

[22]  Guillermina Lozano,et al.  MDM2, an introduction. , 2003, Molecular cancer research : MCR.

[23]  S. Soubeyrand,et al.  Structured DNA promotes phosphorylation of p53 by DNA-dependent protein kinase at serine 9 and threonine 18. , 2004, European journal of biochemistry.

[24]  Jason A. Koutcher,et al.  Identification of a tumour suppressor network opposing nuclear Akt function , 2006, Nature.

[25]  P. Pandolfi,et al.  Role of PML in cell growth and the retinoic acid pathway. , 1998, Science.

[26]  D. Meek,et al.  Protein kinase CK1 is a p53‐threonine 18 kinase which requires prior phosphorylation of serine 15 , 1999, FEBS letters.

[27]  C. Gespach,et al.  Nuclear bodies and compartments: functional roles and cellular signalling in health and disease. , 2004, Cellular signalling.

[28]  M. Stöter,et al.  Casein kinase 1 delta (CK1δ) interacts with the SNARE associated protein snapin , 2006 .

[29]  T. Hunter,et al.  Budding and fission yeast casein kinase I isoforms have dual-specificity protein kinase activity. , 1994, Molecular biology of the cell.

[30]  E. Appella,et al.  Phosphorylation Site Interdependence of Human p53 Post-translational Modifications in Response to Stress* , 2003, Journal of Biological Chemistry.

[31]  T. Maritzen,et al.  Casein kinase I delta (CKIδ) is involved in lymphocyte physiology , 2003 .

[32]  A. Fersht,et al.  Molecular mechanism of the interaction between MDM2 and p53. , 2002, Journal of molecular biology.

[33]  K. Sakaguchi,et al.  Damage-mediated Phosphorylation of Human p53 Threonine 18 through a Cascade Mediated by a Casein 1-like Kinase , 2000, The Journal of Biological Chemistry.